Peptide therapy has become one of the fastest-growing components of functional medicine and hormone optimization practice — and for good reason. Peptides like BPC-157, Sermorelin, Ipamorelin/CJC-1295, PT-141, and Tirzepatide analogs are producing clinically meaningful results in areas ranging from recovery and healing to growth hormone optimization to weight management. But the regulatory landscape for peptide prescribing via telehealth is evolving rapidly, and practitioners need to stay current.
The fundamental regulatory framework: peptides prescribed for individual patients through 503A compounding pharmacies are legal as compounded preparations when there is a valid patient-prescriber relationship, a legitimate clinical indication, and a licensed compounder. The FDA’s ongoing oversight of compounding pharmacies has created some volatility in the availability of specific peptide compounds — BPC-157 was temporarily placed on the FDA’s list of bulk substances not eligible for 503A compounding in 2022, though enforcement and availability through specific pharmacies have varied. Practitioners must check the current status of each peptide compound they intend to prescribe through their specific pharmacy partners.
Clinically, the most established and widely used peptides in hormone optimization practice include Sermorelin and Ipamorelin/CJC-1295 (growth hormone secretagogues, prescribed for adults with age-related growth hormone decline, administered subcutaneously at bedtime to mimic physiological GH pulsatility), BPC-157 (prescribed for tissue healing, gut repair, and joint recovery, administered subcutaneously or orally depending on the target indication), and PT-141 (bremelanotide, FDA-approved for female HSDD, used off-label in men for sexual dysfunction unresponsive to PDE5 inhibitors).
Building peptide prescribing into your practice requires pharmacy relationships with compounders who are current on which peptides they can legally compound and who maintain the quality controls required for sterile injectables. Our training covers peptide prescribing frameworks. Book here. Call 844-734-2112.